[Open, multicenter, phase Ⅳ clinical trial of Shenbei Guchang capsules in treatment of diarrhea type irritable bowel syndrome].

@article{Qiu2016OpenMP,
  title={[Open, multicenter, phase Ⅳ clinical trial of Shenbei Guchang capsules in treatment of diarrhea type irritable bowel syndrome].},
  author={Chun-Hua Qiu and Liang-Ping Li and Chu-Min Zhang and Chunsheng Liu and Tao Liang and Yi Jian and Hong-bin Wang and Yang Zhang and Guang-Shang Wang and Xin-Xi Xie and Shu-An Chen and W Q He and Xu Zhang and Yong-Su Jiang and Jing Liao and Dong Chen and Bi Liu and Wen-Bin Pan},
  journal={Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica},
  year={2016},
  volume={41 10},
  pages={1947-1951}
}
To evaluate the safety and effectiveness of Shenbei Guchang capsules in treatment of diarrhea type irritable bowel syndrome (yang deficiency of spleen and kidney) under widely used conditions, an open, multicenter, controlled, phase Ⅳ clinical trial was conducted in the drug clinical trial centers of 16 domestic hospitals. 2 123 patients from June 10, 2011 to November 29, 2012 were enrolled in the trial. Drug clinical trial was approved by Sichuan Academy of Medical Sciences, Sichuan Provincial… CONTINUE READING